Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study suggests that while Nanostring profiling identifies important processes in resolving MA-ARDS, solely targeting late-stage resolution by altering SPM production is not enough. The researchers conclude that combining multi-targeted adjunctive therapies with antimalarial drugs may be necessary to enhance survival and recovery.

This review discusses the potential use of cannabidiol (CBD) for managing COVID-19 patients, especially for controlling cytokine storms in those with acute respiratory distress syndrome, but reports no new clinical results.

In this study, researchers report that CDK inhibitors like palbociclib and ribociclib, initially developed for cancer therapy, show potential in treating neutrophilic inflammation-related conditions such as ARDS and psoriasis, although their clinical repurposing requires further research on safety and dose adjustments.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

This chapter reviews the epidemiology, clinical manifestations, diagnosis, treatment, and outcomes of severe acute respiratory syndrome (SARS) in children, but presents no new clinical results.